Breaking News
0

The Zacks Analyst Blog Highlights: Johnson & Johnson, NextEra, Deere, Cintas And Canadian Pacific

By Zacks Investment ResearchStock MarketsJul 18, 2019 11:06PM ET
www.investing.com/analysis/the-zacks-analyst-blog-highlights-johnson--johnson-nextera-deere-cintas-and-canadian-pacific-200442066
The Zacks Analyst Blog Highlights: Johnson & Johnson, NextEra, Deere, Cintas And Canadian Pacific
By Zacks Investment Research   |  Jul 18, 2019 11:06PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 

For Immediate Release

Chicago, IL – July 19, 2019 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Johnson & Johnson (NYSE:JNJ) , NextEra (NYSE:NEE) , Deere (NYSE:DE) , Cintas (NASDAQ:CTAS) and Canadian Pacific (NYSE:CP) .

Here are highlights from Thursday’s Analyst Blog:

Top Stock Reports for J&J, NextEra and Deere

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Johnson & Johnson (JNJ), NextEra (NEE) and Deere (DE). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today’s research reports here >>>

Johnson & Johnson's shares have outperformed the Zacks Large Cap Pharmaceuticals industry so far this year (+2.2% vs. -1.2%). J&J beat estimates for earnings and sales in Q2 and raised the 2019 guidance for operational sales growth for the second time this year.

The Zacks analyst thinks J&J is witnessing significant generic/biosimilar headwinds in its Pharma unit in 2019. However, J&J’s sales and earnings growth is expected to accelerate in 2020 supported by contribution from new drugs like Tremfya and successful label expansion of cancer drugs like Imbruvica and Darzalex and immunology drug, Stelara.

J&J is also making rapid progress with its pipeline and line extensions. It has already gained FDA approval for two new drugs in 2019, Balversa and Spravato. Headwinds like biosimilar/generic competition and pricing pressure remain. The talc and opioid litigations are overhangs on the stock.

Shares of NextEra have outperformed the Zacks Electric Power industry in the past year, gaining +23.3% vs +11.8%. The Zacks analyst thinks NextEra’s investments to strengthen renewable operations through “30 by 30” plan will help the company to continue as a market leader in renewable power generation. Focus on expanding operations in natural gas pipelines and further expansion of business through acquisitions and organic growth have positively impacted earnings.

However, its nature of business is subject to complex and comprehensive federal, state, and other regulations. Substantial investments are undertaken to ensure the safety of nuclear operations. If planned outages last longer than expected, or there is an unplanned outage normal operations and profitability might be hindered.

Deere’s shares have gained +16.2% in the past year, underperforming the Zacks Farm Equipment industry, which has increased +14.3% over the same period. For fiscal 2019, Deere expects net sales to increase 5% year over year. Concerns stemming from the U.S-China trade war and lower commodity prices have led to farmers getting cautious about their equipment purchases.

However, the Zacks analyst thinks the $16 billion aid program for American farmers impacted by the trade war is likely to bolster agricultural equipment sales, which bodes well for Deere. Improving construction markets and the Wirtgen acquisition, which has increased Deere's exposure to global transportation infrastructure, will benefit results.

Additionally, introduction of advanced technologies in its products will aid growth. However, raw material cost inflation, elevated expenses and unfavorable foreign currency impact remain near-term headwinds.

Other noteworthy reports we are featuring today include Cintas and Canadian Pacific.

More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple (NASDAQ:AAPL) sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.

Click here for the 6 trades >>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

http://www.zacks.com

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.



Canadian Pacific Railway Limited (CP): Free Stock Analysis Report

NextEra Energy, Inc. (NEE): Free Stock Analysis Report

Johnson & Johnson (JNJ): Free Stock Analysis Report

Cintas Corporation (CTAS): Free Stock Analysis Report

Deere & Company (DE): Free Stock Analysis Report

Original post

Zacks Investment Research
The Zacks Analyst Blog Highlights: Johnson & Johnson, NextEra, Deere, Cintas And Canadian Pacific
 
The Zacks Analyst Blog Highlights: Johnson & Johnson, NextEra, Deere, Cintas And Canadian Pacific

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email